Fox, if the company does have a good relationship with Dr. Subbiah, and they are moving forward in unison, would there be any other possibilities other than what you just suggested?
Or, importantly, the company could be in agreement not to reveal data at ASCO because it would kill a chance at publishing in Nature, Science, Lancet, or New England Journal of Medicine.